Prana Biotechnology (PRAN)

Add to Watchlists
Create an Alert
1.745 +0.01  +0.35% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD

Prana Biotechnology Current Ratio (Quarterly):

5.164 for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Prana Biotechnology Current Ratio (Quarterly) Chart

Pro Export Data
Pro Save Image

Prana Biotechnology Historical Current Ratio (Quarterly) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 5.164
Sept. 30, 2013
June 30, 2013 5.480
March 31, 2013
Dec. 31, 2012 3.803
Sept. 30, 2012
June 30, 2012 4.240
March 31, 2012
Dec. 31, 2011 3.640
Sept. 30, 2011
June 30, 2011 4.304
March 31, 2011
Dec. 31, 2010 3.237
Sept. 30, 2010
June 30, 2010 4.470
March 31, 2010
Dec. 31, 2009 9.476
Sept. 30, 2009
June 30, 2009 5.620
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
   
March 31, 2008 Go Pro
Dec. 31, 2007 Go Pro
Sept. 30, 2007 Go Pro
June 30, 2007 Go Pro
March 31, 2007 Go Pro
Dec. 31, 2006 Go Pro
Sept. 30, 2006 Go Pro
June 30, 2006 Go Pro
March 31, 2006 Go Pro
Dec. 31, 2005 Go Pro
Sept. 30, 2005 Go Pro
June 30, 2005 Go Pro
March 31, 2005 Go Pro
Dec. 31, 2004 Go Pro
Sept. 30, 2004 Go Pro
June 30, 2004 Go Pro
March 31, 2004 Go Pro
Dec. 31, 2003 Go Pro
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Current Ratio

The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More

Get data for
Advertisement

PRAN Current Ratio (Quarterly) Benchmarks

Companies
Halozyme Therapeutics 3.74
Celgene 3.881
Kindred Biosciences

PRAN Current Ratio (Quarterly) Range, Past 5 Years

Minimum 3.237 Dec 2010
Maximum 9.476 Dec 2009
Average 4.943
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.